NEWS

ALACHUA, Fla., Jan. 8, 2024 /PRNewswire/ -- RTI Surgical, an industry leading contract development and manufacturing organization (CDMO), serving the regenerative medicine industry, announced today that it has signed a definitive agreement to acquire Cook Biotech Incorporated, a leader in advanced tissue-repair products from biomaterials, headquartered in West … [Read more...] about RTI Surgical Announces Agreement to Acquire Cook Biotech from Cook Group

CARLSBAD, Calif.--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024. Preliminary total revenue grew approximately 37% … [Read more...] about ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

Thank you Eminent Spine!  On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site in 2024 through your PLATINUM sponsorship. About Eminent Spine Forged in solid biomechanics and the best-known biomaterials, Eminent Spine has emerged as an industry leader in the evolution of spinal implants and instrumentation. Since the introduction … [Read more...] about We are proud to announce that Eminent Spine will be Sponsor of SPINEMarketGroup in 2024!

BROOMFIELD, CO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it has executed a strategic partnership … [Read more...] about Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

BURLINGTON, Mass., Jan. 6, 2024 /PRNewswire-PRWeb/ --Sacrix, a pioneer medical device company in outpatient spine surgery solutions, proudly unveils a novel Less Exposure Spine Surgery (LESS) technique that helped patients avoid major and risky revision corrective spine surgery. The clinical results were summarized in a research paper authored by Board-certified Orthopedic … [Read more...] about Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal

Thank you Centinel Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship! About Centinel Spine, LLC Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically-proven total disc replacement (TDR) … [Read more...] about We are proud to announce that Centinel Spine will be Sponsor of SPINEMarketGroup again in 2024!

Plano, TX, January 04, 2024 --(PR.com)-- Eminent Spine received 510(k) approval of their 3D Titanium Anterior Lumbar Interbody Fusion Stand-Alone System in October of 2022. Since then, Eminent Spine has had a total of 40 3D Titanium ALIF Stand-Alone implants used in procedures in patients who were candidates for an Anterior Lumbar Interbody Fusion. The implants also … [Read more...] about Eminent Spine’s 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study

Thank you Rudischhauser Surgical Instruments and Implants Manufacturing!  On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Rudischhauser Surgical Instruments and Implants Manufacturing Your partner and OE-Manufacturer of superior instruments, implants and complete set … [Read more...] about We are proud to announce that Rudischhauser Surgical Instruments and Implants Manufacturing will be Sponsor of SPINEMarketGroup again in 2024!

With numerous FDA approvals, 2023 has proven to be a landmark year that paves the way for groundbreaking products. As we move into 2024, the spotlight is on American companies, particularly trailblazers like Eminent Spine and Astura Medical, which have been spearheading the approval process and already have captivating portfolios. Eminent Spine, a leading figure in the … [Read more...] about Exciting FDA-Approved Products in the Pipeline for 2024: A Glimpse into the Dynamic Landscape of American Companies

BERN, Switzerland, January 4, 2024 (Newswire.com) - LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This … [Read more...] about LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission

KEELE, England, Jan. 4, 2024 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, is pleased to announce that its investee company, Renovos Biologics (Renovos), has been granted Breakthrough Device … [Read more...] about Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2

Thank you W+S Solutions! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About W+S Solutions GmbH The company W+S Solutions is a family-owned business founded in 2006 in Tuttlingen, Germany. We are specialized in the manufacturing of silicone handles for surgical instruments as … [Read more...] about We are proud to announce that W+S Solutions will be Sponsor of SPINEMarketGroup again in 2024!

SEOUL, South Korea, Jan. 2, 2024 /PRNewswire/ -- CGBio (CEO Hyun Seung Yu), a Korean company specializing in bio-regenerative medicine, announced on the 2nd that its advanced bone substitute material, "NOVOSIS PUTTY", has been granted 'Breakthrough Device Designation' (BDD) by the U.S. Food and Drug Administration (FDA). This material incorporates recombinant … [Read more...] about CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market